Human urine helps prevent bacteria from sticking to bladder cells

June 30, 2015, American Society for Microbiology

Human urine contains factors that prevent a common culprit in urinary tract infections (UTIs), uropathogenic Escherichia coli bacteria, from properly attaching to bladder cells, a necessary step for infection. The research, published this week in mBio, the online open-access journal of the American Society for Microbiology, reveals a weakness that could be exploited to develop more effective, non-antibiotic treatments for UTIs.

"There is a pressing, unmet need when it comes to developing new and better ways to treat UTIs," says Scott Hultgren, the Helen L. Stoever professor of molecular microbiology at Washington University School of Medicine in St. Louis who oversaw the study. Of the 10 million cases of UTI in the US each year, approximately 1 million are chronic recurrent cases. Those cases are of particular concern, says Hultgren, because they often involve bacteria that have become resistant to multiple antibiotics used to fight these infections.

"This study gives us a better understanding of the mechanism by which bacteria are able to colonize the ," says Hultgren. "Like an electrician, we have a molecular blueprint of the process and we can try to find a node to short-circuit the pathogenic cascade."

Hultgren's laboratory studies the uropathogenic E. coli (UPEC) bacteria that cause the vast majority of UTIs. A single UPEC bacterium can have hundreds of tiny hair-like structures called type 1 pili that help it attach to the walls of the bladder. The pili tips are made of FimH adhesin, a protein that tightly binds to a mannose sugar molecule decorating the outer surface of bladder cells. This attachment triggers bacterial invasion of these cells.

"Once the bacteria are able to invade that bladder epithelial cell, it becomes a safe haven where the bacteria rapidly replicate and gain a foothold for infection in the bladder," says Hultgren.

His group took a closer look at the assembly of these pili structures so key to infection. Because bacteria found in human urine are often missing these pili, Hultgren's team wondered if something in the urine itself caused the bacteria to halt assembly of these structures. Pilus assembly is controlled by an entire set of genes called the fim operon, which can be switched to ON or OFF phases by different signals.

When the researchers looked at UPEC grown in human urine from healthy individuals, they found that something in the urine switched all the fim operons to the OFF mode and kept them there. However, if UPEC bacteria were already attached via FimH to bladder cells grown in a lab dish, urine lost this effect.

Upon further inspection, the team also found that unknown factors in urine interfere with the bacterial FimH protein's ability to adhere to cells. In addition, when FimH function is disrupted in other ways—by genetic mutation or chemical inhibition—this disruption also causes the genetic machinery to switch to the OFF phase, preventing further pilus formation.

"This was one of the big surprises," says Hultgren. "It's as if the bacteria senses that it has a non-functional adhesin and it switches off the whole pilus production assembly." This exposes a crucial weakness in this pathogen's ability to infect.

"Based on the mouse model, the crux of the whole infection cascade is the FimH attachment. If you don't have that, the bacteria can't stick to the bladder, invade, or cause infection," Hultgren notes. This means that drugs such as mannosides, chemical inhibitors that block FimH's attachment to cells, could work even more effectively by also keeping pilus gene expression switched off. Such drugs would block the from attaching and invading, so the body could simply flush them out in the urine flow.

Hultgren cautions that it will be a huge challenge to determine if the findings in the laboratory translate to human patients. But if so, Hultgren says, it would give drug developers a powerful, non-antibiotic way to fight UPEC: "FimH could be the Achilles' heel of UTIs."

Explore further: Boosting the body's natural ability to fight urinary tract infections

Related Stories

Boosting the body's natural ability to fight urinary tract infections

April 30, 2015
Urinary tract infections (UTIs) are common, and widespread antibiotic resistance has led to urgent calls for new ways to combat them. Researchers at University of California, San Diego School of Medicine and Skaggs School ...

Antibody's unusual abilities might inspire vaccine strategies

May 14, 2015
The recent discovery of a novel antibody that works in an unusual way might inspire ideas for designing more effective vaccines. Among the common pathogens that could be targeted are urinary-tract infecting strains of E. ...

Bladder cells regurgitate bacteria to prevent urinary tract infections

May 28, 2015
Duke Medicine researchers have found that bladder cells have a highly effective way to combat E. coli bacteria that cause urinary tract infections (UTIs).

Experimental drug clears chronic urinary infections in mice

November 16, 2011
An experimental treatment for urinary tract infections has easily passed its first test in animals, alleviating weeks-long infections in mice in as little as six hours.

Recommended for you

Researchers seek vaccine for 'traveler's diarrhea'

September 25, 2018
Every year, millions of people have vacations and business trips ruined when they succumb to "traveler's diarrhea" during their journeys. A major cause of traveler's diarrhea is bacteria called Enterotoxigenic E. coli, or ...

Experimental vaccine shows promise in preventing TB

September 25, 2018
(HealthDay)—Tuberculosis remains the most lethal of infectious diseases worldwide, killing more than 1.6 million people a year. But researchers say a new vaccine might prevent half of full-blown illnesses in infected people ...

Many doctors in India miss TB signs: study

September 25, 2018
Many private sector doctors in India miss the signs of tuberculosis and therefore provide patients inadequate treatment, according to a new study published Tuesday involving people hired to act out the symptoms.

New way of determining treatment for staph infections cuts antibiotic use

September 25, 2018
Using a clinical checklist to identify eligible patients, doctors were able to shorten the antibiotic duration for patients with uncomplicated staphylococcal bloodstream infections by nearly two days, Duke Health researchers ...

Breakthrough in designing a better Salmonella vaccine

September 24, 2018
UC Davis researchers announce in the Proceedings of the National Academy of Sciences this week a breakthrough in understanding which cells afford optimal protection against Salmonella infection—a critical step in developing ...

Antifungal agent found to be possible treatment for porphyria

September 24, 2018
A large team of researchers from Spain, France and the U.S. has found that a common antifungal agent might be useful as a treatment for a rare type of porphyria. In their paper published in the journal Science Translational ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.